2011

Scios, a Johnson & Johnson subsidiary, pled guilty on Thursday for falsely marketing Natrecor, a heart failure drug, according to recent news sources. Scios was charged with a misdemeanor violation of the Food, Drug and Cosmetic Act. The U.S. has also sued Scios in a related case under the False Claims Act in California. Scios… read more

Johnson & Johnson is conducting yet another recall, this time of its Eprex anemia drug, due to a lack of potency, according to recent news sources. The recall affects about 200,000 syringes of the Eprex anemia drug. The drug is sold at the wholesale and pharmacy level. Johnson & Johnson believes most of the product… read more

A negative review from the Food and Drug Administration recommends against Xarelto, an anti blood clotting drug used to prevent strokes in those with atrial fibrillation, according to news sources. Atrial fibrillantion is a heart-rhythm disorder that increases one’s chance of a stroke. According to the staff review of the drug released by Bayer and… read more

A Johnson & Johnson CEO paid more than any other pharmaceutical company CEO may be forced to pay back a large amount of that compensation in a recent shareholder lawsuit, according to news reports. The CEO in question has been paid more than $150 million since 2006. Shareholders argue that this is “lavish and excessive”… read more

Johnson & Johnson announced Monday that it is recalling over two million packages of over-the-counter Tylenol brand cold medicine due to an excessive amount of a chemical compound found in the drug, report news sources Subject to recall are almost 2.5 million packages of Tylenol Cold Multi-Symptom Nighttime Rapid Release Gelcaps. The cold relief medicine… read more